Irina Arp, MD
Surgery · Grove City, OHNPI 1558625780
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $814 and has fallen 52.1% since, to $390 in 2025.
Across 127 payments — averaging $23.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$555
- AbbVie$524
- Intuitive Surgical$353
- Smith+Nephew$261
- Takeda Pharmaceuticals U.S.A., Inc.$212
- Vertex$194
- plus $844 from 14 others
What the payments were for
- Food & beverage$2,90999%
- Education$331%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 28 | $555 |
| AbbVie | 44 | $524 |
| Intuitive Surgical | 9 | $353 |
| Smith+Nephew | 7 | $261 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $212 |
| Vertex | 4 | $194 |
| Endomagnetics Ltd | 2 | $175 |
| Davol Inc. | 2 | $165 |
| Novo Nordisk | 6 | $127 |
| Johnson & Johnson(2 entities) | 2 | $98 |
| Integra Lifesciences Corporation | 1 | $60 |
| Merck | 3 | $43 |
| TELA Bio, Inc. | 2 | $35 |
| Endo Pharmaceuticals Inc. | 2 | $30 |
| Innocoll Pharmaceuticals Limited | 1 | $22 |
| Dilon Technologies, Inc. | 1 | $22 |
| AstraZeneca | 1 | $20 |
| Organogenesis Inc. | 1 | $17 |
| KCI USA, Inc. | 1 | $15 |
| Boston Scientific | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Magseed$162
- Magtrace$162
- Phasix Mesh$142
- JOURNAVX$122
- Da Vinci Surgical System$108
- STRAVIX PL$103
- Kcentra$102
How this compares
$2,942 in reported general payments places this provider in the 60th percentile of 988 surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Letrozole | 25 | $678 |
Paid to pharmacies, not to this prescriber.
Other surgery in Grove City
- Jonathan ThompsonWest Chester$2.1M
- Raymond OndersCleveland$1.2M
- Neilendu KunduCleveland$808K
- Michael MearaColumbus$808K
- Chase WehrleCleveland$741K
- Craig JarrettCleveland$622K
- Greg StarleyCuyahoga Falls$594K
- Ihya GorgunCleveland$527K
- Marshall SpaldingColumbus$450K
- Jason ShoemakerDublin$344K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.